Core Laboratories (CLB) Stock Price, News & Analysis

Company Overview

Core Laboratories N.V. (NYSE: CLB) is a global provider of proprietary and patented reservoir description and production enhancement services to the energy industry. Its customers include oil and natural gas exploration and production companies, national oil companies, and independent operators.

The company’s reservoir description activities include the analysis of rock and fluid samples, core and special core analysis, petrophysical services, geological and reservoir modeling, and laboratory measurements used to evaluate hydrocarbon reservoirs and improve field development decisions. These services help customers assess reservoir properties, estimate recoverable resources, and plan drilling and production programs.

Core Laboratories’ production enhancement business provides services and technologies intended to improve well performance and hydrocarbon recovery. Its offerings include completion and stimulation evaluation, well intervention and production optimization services, and technologies designed for conventional, unconventional, offshore, and enhanced oil recovery projects. The company serves energy markets across North America and international regions through a global network of laboratories, facilities, and field operations.

Key Stats

• Today's Range: $10.08 to $10.25
• 50-Day Range: $9.70 to $12.67
• 52-Week Range: $9.48 to $20.36
• Volume: 491,859 shs
• Average Volume: 584,824 shs
• Market Capitalization: $464.54 million
• P/E Ratio: 18.08
• Dividend Yield: 0.40%
• Price Target: $21.00
• Consensus Rating: Hold

Core Laboratories Stock Analysis - MarketRank™

Core Laboratories scored higher than 84% of companies evaluated by MarketBeat, and ranked 54th out of 243 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

Core Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Core Laboratories has a consensus price target of $21.00, representing about 105.9% upside from its current price of $10.20.

Amount of Analyst Coverage

Core Laboratories has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 41.07%

Earnings Growth

Earnings for Core Laboratories are expected to grow by 41.07% in the coming year, from $0.56 to $0.79 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Core Laboratories is 18.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.89.

Price to Earnings Ratio vs. Sector

The P/E ratio of Core Laboratories is 18.21, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 20.43.

Price to Earnings Growth Ratio

Core Laboratories has a PEG Ratio of 2.03. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Core Laboratories has a P/B Ratio of 1.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

10.74% of the float of Core Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Core Laboratories has a short interest ratio ("days to cover") of 6.81.

Change versus previous month

Short interest in Core Laboratories has recently increased by 11.07%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Core Laboratories has a dividend yield of 0.39%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Core Laboratories does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Core Laboratories is 7.14%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 5.06% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Core Laboratories this week, compared to 2 articles on an average week.

Search Interest

4 people have searched for CLB on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

2 people have added Core Laboratories to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 3.6 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $53,900.00 in company stock, which represents 0.0115% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Core Laboratories insiders have bought more of their company's stock than they have sold. Specifically, they have bought $53,900.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

1.26% of the stock of Core Laboratories is held by insiders.

Percentage Held by Institutions

97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/29/2026
• Record date for 8/31 Dividend: 8/10/2026
• Ex-Dividend for 8/31 Dividend: 8/10/2026
• Dividend Payable: 8/31/2026
• Today: 10/21/2026
• Next Earnings (Estimated): 10/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Energy
• Industry: Energy Equipment & Services
• Sub-Industry: Oil & Gas Equipment & Services
• Current Symbol: NYSE:CLB
• CIK: 1958086
• Web: www.corelab.com
• Phone: (713) 328-2673
• Fax: N/A
• Employees: 3,300
• Year Founded: 1936

Price Target and Rating

• Average Price Target for Core Laboratories: $21.00
• High Price Target: $21.00
• Low Price Target: $21.00
• Potential Upside/Downside: +107.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.56
• Trailing P/E Ratio: 18.08
• Forward P/E Ratio: 18.08
• P/E Growth: 2.03
• Net Income: $29.67 million
• Net Margins: 5.10%
• Pretax Margin: 7.09%
• Return on Equity: 10.03%
• Return on Assets: 4.71%

Debt

• Debt-to-Equity Ratio: 0.41
• Current Ratio: 2.12
• Quick Ratio: 1.55

Sales & Book Value

• Annual Sales: $526.52 million
• Price / Sales: 0.88
• Cash Flow: $1.07 per share
• Price / Cash Flow: 9.50
• Book Value: $5.85 per share
• Price / Book: 1.73

Miscellaneous

• Outstanding Shares: 45,880,000
• Free Float: 45,307,000
• Market Cap: $464.54 million
• Optionable: Optionable
• Beta: 1.14